Ligand validation:3W68

VIV: (2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL

VIV is a Ligand Of Interest in 3W68 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3W68_VIV_C_301	29%	42%	0.274	0.936	1.1	1.15	3	5	1	0	100%	1
3W68_VIV_A_301	26%	46%	0.309	0.954	1.01	1.09	2	4	2	0	100%	1
3W68_VIV_B_301	26%	44%	0.28	0.921	1.18	0.98	5	2	0	0	100%	1
3W68_VIV_D_301	25%	46%	0.262	0.897	0.97	1.12	2	4	1	0	100%	1
3W67_VIV_B_301	36%	41%	0.25	0.945	0.98	1.29	2	6	1	0	100%	1
1R5L_VIV_A_301	84%	53%	0.086	0.946	0.84	0.97	1	2	0	0	100%	1
6ZPD_VIV_A_301	71%	37%	0.141	0.967	1.27	1.2	2	4	0	0	97%	0.9677
5MUE_VIV_A_302	69%	45%	0.162	0.977	1.17	0.98	2	2	0	0	100%	1
5MUG_VIV_A_301	66%	46%	0.162	0.968	1.15	0.93	2	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.